Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $235,420 | 275 | 99.9% |
| Food and Beverage | $134.64 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $235,420 | 275 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $121.83 | 1 | $0 (2024) |
| Romark Laboratories, LC | $12.81 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $32,341 | 49 | ABBVIE INC. ($32,219) |
| 2023 | $41,133 | 42 | AbbVie Inc. ($41,133) |
| 2022 | $16,168 | 20 | ABBVIE INC. ($16,168) |
| 2021 | $26,257 | 36 | AbbVie Inc. ($26,257) |
| 2020 | $24,073 | 25 | AbbVie Inc. ($24,073) |
| 2019 | $29,207 | 35 | AbbVie, Inc. ($29,207) |
| 2018 | $26,248 | 31 | AbbVie, Inc. ($26,248) |
| 2017 | $40,128 | 39 | AbbVie, Inc. ($40,115) |
All Payment Transactions
277 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 12/23/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 12/16/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 12/09/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,207.28 | General |
| 12/02/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,207.28 | General |
| 11/18/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 11/11/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 11/04/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 10/28/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 10/21/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 10/14/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 10/07/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 09/30/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 09/23/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 09/16/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 09/09/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 09/02/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 08/26/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 08/19/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 08/12/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 08/05/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 07/29/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 07/15/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 07/01/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
| 06/24/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $603.64 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 303 | 314 | $109,275 | $17,102 |
| 2022 | 7 | 309 | 322 | $101,807 | $19,243 |
| 2021 | 4 | 235 | 240 | $84,175 | $17,429 |
| 2020 | 9 | 344 | 393 | $106,453 | $17,012 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 82 | $40,180 | $6,674 | 16.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 114 | 121 | $39,930 | $6,141 | 15.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 53 | 53 | $25,705 | $3,361 | 13.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 16 | 16 | $1,200 | $553.92 | 46.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 16 | 20 | $1,600 | $324.40 | 20.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 22 | 22 | $660.00 | $48.40 | 7.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 129 | $40,377 | $7,888 | 19.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 80 | $37,200 | $6,779 | 18.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 43 | 43 | $19,780 | $3,386 | 17.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 20 | 20 | $1,400 | $659.58 | 47.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 14 | 18 | $1,440 | $276.71 | 19.2% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 13 | 13 | $1,040 | $211.57 | 20.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 19 | 19 | $570.00 | $42.23 | 7.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 89 | 92 | $40,020 | $7,848 | 19.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 113 | 115 | $33,925 | $7,480 | 22.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 22 | 22 | $9,460 | $1,748 | 18.5% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 11 | 11 | $770.00 | $353.30 | 45.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 128 | 135 | $56,160 | $8,968 | 16.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 102 | 107 | $30,067 | $5,152 | 17.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 33 | 33 | $13,431 | $1,785 | 13.3% |
| 87426 | Coronavirus ag ia | Office | 2020 | 11 | 11 | $770.00 | $388.63 | 50.5% |
| 87804 | Detection test for influenza virus | Office | 2020 | 12 | 24 | $1,872 | $358.82 | 19.2% |
| 87880 | Strep test (streptococcus, group a) | Office | 2020 | 13 | 14 | $1,120 | $213.24 | 19.0% |
| 94640 | Respiratory inhaled pressure or nonpressure treatment to relieve airway obstruction or for sputum specimen | Office | 2020 | 13 | 13 | $2,431 | $78.03 | 3.2% |
| 81002 | Urinalysis, manual test | Office | 2020 | 20 | 20 | $580.00 | $68.83 | 11.9% |
About Dr. James Samuel, M.D
Dr. James Samuel, M.D is a Emergency Medicine healthcare provider based in Mount Pleasant, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104949635.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Samuel, M.D has received a total of $235,554 in payments from pharmaceutical and medical device companies, with $32,341 received in 2024. These payments were reported across 277 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($235,420).
As a Medicare-enrolled provider, Samuel has provided services to 1,191 Medicare beneficiaries, totaling 1,269 services with total Medicare billing of $70,786. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Emergency Medicine, Family Medicine
- Location Mount Pleasant, WI
- Active Since 04/09/2007
- Last Updated 03/10/2025
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1104949635
Products in Payments
- AIRSUPRA (Drug) $121.83
- Alinia Tablets 500mg 30 count bottle (Drug) $12.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Mount Pleasant
Dr. Christopher Michaelis, D.o, D.O
Emergency Medicine — Payments: $164,039
Dr. Scott Smith, M.d, M.D
Emergency Medicine — Payments: $68,502
Dr. David Wright, M.d, M.D
Emergency Medicine — Payments: $620.14
Dr. Michael Bauerschmidt, Md, MD
Emergency Medicine — Payments: $574.41
Dr. Joseph Humphrey, M.d, M.D
Emergency Medicine — Payments: $562.38
Thomas Hilliard, M.d, M.D
Emergency Medicine — Payments: $161.57